Compounds > 5-methylcytosine
Page last updated: 2024-08-24

5-methylcytosine and Prostatic Neoplasms, Castration-Resistant

5-methylcytosine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, S; Liu, Z; Wan, F; Wang, J; Xu, W; Ye, D; Zhang, H; Zhu, W1

Other Studies

1 other study(ies) available for 5-methylcytosine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression.
    Clinical and translational medicine, 2022, Volume: 12, Issue:9

    Topics: 5-Methylcytosine; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Epigenesis, Genetic; Humans; Male; Methyltransferases; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; RNA, Messenger

2022